HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
1.530
-0.030 (-1.92%)
At close: Jun 12, 2025, 4:00 PM
1.530
0.00 (0.00%)
After-hours: Jun 12, 2025, 4:04 PM EDT
HeartBeam Employees
HeartBeam had 21 employees as of December 31, 2024. The number of employees increased by 6 or 40.00% compared to the previous year.
Employees
21
Change (1Y)
6
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$967,905
Market Cap
51.73M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21 | 6 | 40.00% |
Dec 31, 2023 | 15 | 0 | - |
Dec 31, 2022 | 15 | 10 | 200.00% |
Dec 31, 2021 | 5 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
BEAT News
- 4 weeks ago - HeartBeam, Inc. (BEAT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - HeartBeam Reports First Quarter 2025 Results - Business Wire
- 5 weeks ago - HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio - Business Wire
- 5 weeks ago - HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth - Business Wire
- 6 weeks ago - HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time - Business Wire
- 6 weeks ago - HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology - Business Wire
- 7 weeks ago - HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation - Business Wire
- 3 months ago - HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript - Seeking Alpha